K.C. Pharmaceuticals has voluntarily recalled more than 3.1 million bottles of over‑the‑counter eye drops amid concerns it could not guarantee product sterility. The Food and Drug Administration logged the recall after the company distributed the products through major retailers, including Walgreens, Kroger and CVS. The recall was initiated on March 3 and the FDA formally classified it as a Class II recall on March 31 — indicating that use may cause temporary health effects but serious outcomes are unlikely.
Officials say there have been no reported illnesses linked to these lots. The recall stems from the manufacturer’s inability to assure sterility, not from a confirmed contaminant or identified microbe.
Recalled products
– Sterile Eye Drops AC
– Eye Drops Advanced Relief
– Dry Eye Relief Eye Drops
– Ultra Lubricating Eye Drops
– Sterile Eye Drops Original Formula
– Sterile Eye Drops Redness Lubricant
– Sterile Eye Drops Soothing Tears
– Artificial Tears Sterile Lubricant Eye Drops
If you have any of the listed items, stop using them and discard the product. CVS said the four items it sold were discontinued nearly a year ago and that customers may return affected products for a refund; other retailers are coordinating the recall and will provide return or disposal instructions to customers.
What experts say
Specialists note that this recall creates uncertainty rather than a confirmed safety threat. Gary Novack, PhD, a clinical professor and ophthalmic consultant, pointed out the manufacturer reported a sterility concern but there’s no confirmed contamination identified. Sylvia Groth, MD, an ophthalmologist, said such recalls can undermine public confidence in eye care products and complicate clinicians’ recommendations going forward.
Prescription eye drops are not part of this recall. Patients should continue using prescribed medications for glaucoma, infections, dry eye or other eye conditions unless their doctor advises otherwise.
Why this matters: past outbreaks and risk factors
Health officials point to prior outbreaks to explain the seriousness of manufacturing and sterility lapses. In 2023, contaminated eye drops were linked to an outbreak that caused more than 80 infections and four deaths in the U.S.; investigators found antibiotic‑resistant Pseudomonas aeruginosa and manufacturing problems in that case. Experts have also noted that temporary pauses in FDA inspections during the COVID‑19 pandemic may have allowed some manufacturing issues to go undetected.
Signs of a possible eye infection
If you used a recalled product and develop any concerning symptoms, seek medical attention. Watch for:
– Eye discharge
– Pain or persistent discomfort
– Redness or swelling
– Blurry or reduced vision
Those symptoms can also result from allergies or other noninfectious causes, so monitor progression and consult a clinician if symptoms worsen or do not improve. Contact lens wearers are at higher risk for complications because lenses can cause tiny abrasions and can harbor bacteria.
How to reduce risks when using eye drops
– Wash your hands before applying drops.
– Avoid touching the bottle tip to your eye, lashes, or any surface.
– Discard single‑use vials immediately after use.
– Use trusted brands or follow your doctor’s recommendation for specific products.
If you’re worried you used a recalled product or are experiencing symptoms, contact your healthcare provider or local pharmacy for guidance and next steps.